Transplantation of Human-Induced Pluripotent Stem Cell-Derived Neural Precursors into Early-Stage Zebrafish Embryos

被引:0
|
作者
J. Strnadel
H. Wang
C. Carromeu
A. Miyanohara
K. Fujimura
E. Blahovcova
V. Nosal
H. Skovierova
R. Klemke
E. Halasova
机构
[1] University of California,Department of Pathology
[2] University of California,Department of Anesthesiology
[3] University of California,Department of Pediatrics
[4] Comenius University in Bratislava,Department of Molecular Medicine, Biomedical Center Martin, Jessenius Faculty of Medicine in Martin
来源
关键词
Zebrafish; Human iPS cells; iPS cell-derived neural precursors; Cell grafting;
D O I
暂无
中图分类号
学科分类号
摘要
Induced pluripotent stem cells (iPS cells) generated from somatic cells through reprogramming hold great promises for regenerative medicine. However, how reprogrammed cells survive, behave in vivo, and interact with host cells after transplantation still remains to be addressed. There is a significant need for animal models that allow in vivo tracking of transplanted cells in real time. In this regard, the zebrafish, a tropical freshwater fish, provides significant advantage as it is optically transparent and can be imaged in high resolution using confocal microscopy. The principal goal of this study was to optimize the protocol for successful short-term and immunosuppression-free transplantation of human iPS cell-derived neural progenitor cells into zebrafish and to test their ability to differentiate in this animal model. To address this aim, we isolated human iPS cell-derived neural progenitor cells from human fibroblasts and grafted them into (a) early (blastocyst)-stage wild-type AB zebrafish embryos or (b) 3-day-old Tg(gfap:GFP) zebrafish embryos (intracranial injection). We found that transplanted human neuronal progenitor cells can be effectively grafted and that they differentiate and survive in zebrafish for more than 2 weeks, validating the model as an ideal platform for in vivo screening experiments. We conclude that zebrafish provides an excellent model for studying iPS cell-derived cells in vivo.
引用
收藏
页码:351 / 358
页数:7
相关论文
共 50 条
  • [41] Determination of Appropriate Stage of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Screening and Pharmacological Evaluation In Vitro
    Shinozawa, Tadahiro
    Imahashi, Kenichi
    Sawada, Hiroshi
    Furukawa, Hatsue
    Takami, Kenji
    JOURNAL OF BIOMOLECULAR SCREENING, 2012, 17 (09) : 1192 - 1203
  • [42] Challenges and innovation: Disease modeling using human-induced pluripotent stem cell-derived cardiomyocytes
    Reilly, Louise
    Munawar, Saba
    Zhang, Jianhua
    Crone, Wendy C. C.
    Eckhardt, Lee L. L.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [43] Human-induced Pluripotent Stem Cell-derived Cardiomyocytes as a Model for Trastuzumab-Induced Cardiac Dysfunction
    Kitani, Tomoya
    Ong, Sang-Ging
    Lam, Chi K.
    Rhee, June-Wha
    Zhang, Joe Z.
    Oikonomopoulos, Angelos
    Ma, Ning
    Tian, Lei
    Lee, Jaecheol
    Telli, Melinda L.
    Witteles, Ronald M.
    Sharma, Arun
    Sayed, Nazish
    Wu, Joseph C.
    CIRCULATION RESEARCH, 2019, 125
  • [44] The effect of magnetic nanoparticles on neuronal differentiation of induced pluripotent stem cell-derived neural precursors
    Jirakova, Klara
    Seneklova, Monika
    Jirak, Daniel
    Turnovcova, Karolina
    Vosmanska, Magda
    Babic, Michal
    Horak, Daniel
    Veverka, Pavel
    Jendelova, Pavla
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2016, 11 : 6267 - 6281
  • [45] Characterization of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Bioenergetics and Utilization in Safety Screening
    Rana, Payal
    Anson, Blake
    Engle, Sandra
    Will, Yvonne
    TOXICOLOGICAL SCIENCES, 2012, 130 (01) : 117 - 131
  • [46] Recent advances in regulating the proliferation or maturation of human-induced pluripotent stem cell-derived cardiomyocytes
    Yang, Hao
    Yang, Yuan
    Kiskin, Fedir N.
    Shen, Mengcheng
    Zhang, Joe Z.
    STEM CELL RESEARCH & THERAPY, 2023, 14 (01)
  • [47] Cardiac Toxicity From Ethanol Exposure in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Rampoldi, Antonio
    Singh, Monalisa
    Wu, Qingling
    Duan, Meixue
    Jha, Rajneesh
    Maxwell, Joshua T.
    Bradner, Joshua M.
    Zhang, Xiaoyu
    Saraf, Anita
    Miller, Gary W.
    Gibson, Greg
    Brown, Lou Ann
    Xu, Chunhui
    TOXICOLOGICAL SCIENCES, 2019, 169 (01) : 280 - 292
  • [48] Regulation of ICa,L and force by PDEs in human-induced pluripotent stem cell-derived cardiomyocytes
    Saleem, Umber
    Ismaili, Djemail
    Mannhardt, Ingra
    Pinnschmidt, Hans
    Schulze, Thomas
    Christ, Torsten
    Eschenhagen, Thomas
    Hansen, Arne
    BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (13) : 3036 - 3045
  • [49] Cardiac proarrhythmic risk assessment using human-induced pluripotent stem cell-derived cardiomyocytes
    Albert, Verena
    Jahic, Mirza
    Servant, Nicole
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2023, 123
  • [50] Cardiac toxicity from bisphenol A exposure in human-induced pluripotent stem cell-derived cardiomyocytes
    Hyun, Sung-Ae
    Lee, Chang Youn
    Ko, Moon Yi
    Chon, Sun-Hwa
    Kim, Ye-Ji
    Seo, Jeong-Wook
    Kim, Kee K.
    Ka, Minhan
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2021, 428